research Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
Ritlecitinib effectively treats alopecia areata and is well-tolerated.



Bucaramanga, Colombia
Rome, Italy
Quarto Oggiaro, Italy
Incomplete name
Philadelphia, PA, United States
Karachi, Pakistan
Dubai, United Arab Emirates